OpenAI and Molecule.one have utilized a near-autonomous AI chemist, powered by GPT-5.4, to enhance a complex reaction in medicinal chemistry. This AI-driven approach has improved a key drug-making process, demonstrating the potential of AI to advance pharmaceutical research. The collaboration underscores the role of AI in solving intricate chemical challenges, potentially speeding up drug development. This marks a significant step in the application of AI to scientific research, particularly in the field of chemistry.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
AI News · April 29, 2026 · Background
Microsoft Research · May 12, 2026 · Background
TechCrunch AI · May 18, 2026 · Background
MIT News AI · May 20, 2026 · Related
Microsoft Research · May 21, 2026 · Background
The AI Daily Brief · May 24, 2026 · Background
OpenAI · June 3, 2026 · Background
WIRED AI · July 12, 2026 · Related
TechCrunch AI · July 15, 2026 · Background
MIT Technology Review AI · July 23, 2026 · Related
MIT Technology Review AI · July 27, 2026 · Related
OpenAI · September 10, 2026 · Related